Video Colonoscopes – i10 Series HD+
The i10 Series HD+ Colonoscopes are PENTAX Medical’s premium line of endoscopes for screening, diagnostic and therapeutic treatment in the lower GI tract. The i10 Colonoscopes are available in both standard and slim insertion tube diameters and both equipped with a large 3.8mm instrument channel. The i10 Series HD+ Colonoscopes deliver the best imaging, therapeutic opportunity and ergonomic comfort within the PENTAX Medical Colonoscopy Product Line.
Next generation imaging system with HD+™ CCDs, CloseFocus™ and i-SCAN™
The i10 Series HD+ Colonoscopes are equipped with second-generation HD+ Megapixel Resolution CCDs for exceptional image clarity and detail resolution. Both scopes can be used with i-SCAN™ image enhancement technology that provides the user with an enhanced view of the texture of the mucosal surface and the blood vessels. The EC34-i10L features CloseFocus™ Examination Range allows the physician to get as close as 2mm from the mucosa for even greater resolving power and magnified visualization of the tissue and capillary networks automatically, without the need for button activation.
Improved ergonomic design and control
Endoscopist’s daily procedure volume is growing and putting more pressure on the endoscopist to do more cases and reduce procedure times. The i10 Series HD+ Colonoscopes are designed with a new ergonomic control body to better support higher case volumes and overall comfort in the physician’s hand. With PENTAX Medical i-FLEX™ Graduated Stiffness Insertion Tubes featuring TrueTorque™ Design, the i10 Series HD+ Colonoscopes are designed to balance efficiency, consistency and patient comfort in colonoscopy.
PENTAX Medical launches MILES FOR HEALTH™ campaign to celebrate the 100-year anniversary of its origin
The global MILES FOR HEALTH™campaign aims to raise awareness of the importance of cancer research, with PENTAX Medical set to donate up to US$125,000 for World Cancer Research Fund.
Through its MILES FOR HEALTH™ campaign, PENTAX Medical will donate an additional US$1 to charity* for every mile covered by anyone who registers
For more info, please visit the MILES FOR HEALTHTM website - www.milesforhealth.com
Tokyo, 29th May 2019 – PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundation of Asahi Optical Joint Stock Co., the original manufacturer of PENTAX-branded products. To commemorate this achievement, PENTAX Medical will donate up to US$25,000 in addition to the US$100,000 already pledged to the World Cancer Research Fund. This gesture echoes the company’s ongoing commitment to help improve the awareness, detection, diagnosis and treatment of cancer, which is a value at the core of PENTAX Medical’s history
On 29th May 2019, the company will also launch its “MILES FOR HEALTH™ - 100 Years of PENTAX campaign” to help raise awareness of the importance of cancer research. Anyone, including staff, partners and customers, across the globe will be able to register to take part. Whether it’s one mile or a marathon, everyone will be able to do their bit to help raise money for the World Cancer Research Fund. These miles can be achieved by any method of self-propulsion such as running or walking, and any distance will count – small or large.
Gerald W. Bottero, Global President, PENTAX Medical said, “It is an honor to preside over this landmark moment in our Company’s great history. I am delighted that we are able to celebrate this remarkable achievement with a charitable gesture, one that we hope reflects our ongoing commitment to the improved awareness, detection, diagnosis and treatment of cancer.”
Dr Giota Mitrou, Director of Research at World Cancer Research Fund, said: “We are extremely grateful to PENTAX Medical for their incredibly generous donation. This sum of money will help fund vital research into cancer prevention and survival as well as enable us to continue empowering people to lower their risk of cancer. We want to live in a world where no one develops a preventable cancer and this money will go towards our efforts.”
With a rich history of innovation, initially manufacturing spectacle lenses and later camera lenses, PENTAX first entered the endoscopy market in 1977 with the FB-17A – it’s first Broncho Fiberscope. Since then, endoscopy has become a vital tool in the detection, diagnosis and treatment of many cancers. Now a division of HOYA Group, PENTAX Medical continues to innovate, developing leading-edge optical technologies, including cutting-edge solutions that support each step of the clinical pathway. From screening to diagnosis and into therapy, PENTAX Medical offers clinicians various advanced solutions to enhance productivity and improve patient outcome.
Working towards the next 100 years and beyond, PENTAX Medical’s mission is to continue aiding the global medical community, providing quality, innovative and easy-to-use endoscopic products and services. Together with its customers and partners around the world, PENTAX Medical is committed to help improve the detection, diagnosis and treatment of cancer.
*up to a total of US$25,000
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.
For more information, please visit: www.pentaxmedical.com.
About World Cancer Research Fund
World Cancer Research Fund is one of the world’s leading cancer prevention charities, and is dedicated to funding life-changing research into the prevention of cancer through diet and lifestyle. We cut through the jargon to turn the latest global research on cancer prevention and survival into practical, straightforward advice and information, helping anyone who wants to reduce their risk of developing cancer to make fully informed lifestyle choices.
Find out more: www.wcrf-uk.org
Does Secondary Furlow Palatoplasty Worsen Palatal Motion?
Click to learn how Furlow Palatoplasty potentially misaligns/scars soft palate musculature.
Posted Mar 15, 2017More
Optimizing Diagnostic Yields of EUS-Guided Liver Biopsy: An Assessment of Tissue Acquisition Techniques and Needle Types
Click to read more about EUS-Guided tissue acquisition assessment techniques and needle types.
Posted Mar 14, 2017More